tiprankstipranks
Dermata Therapeutics completes enrollment in DMT310 Phase 3 STAR-1 trial
PremiumThe FlyDermata Therapeutics completes enrollment in DMT310 Phase 3 STAR-1 trial
3M ago
Dermata Therapeutics files to sell 5.87M shares of common stock for holders
Premium
The Fly
Dermata Therapeutics files to sell 5.87M shares of common stock for holders
5M ago
Morning Movers: Intel jumps after announcing AWS collaboration
Premium
The Fly
Morning Movers: Intel jumps after announcing AWS collaboration
5M ago
Dermata Therapeutics announces exercise of warrants for $2.66M
PremiumThe FlyDermata Therapeutics announces exercise of warrants for $2.66M
9M ago
Dermata Therapeutics reports Q1 EPS (47c) vs. ($2.27) last year
Premium
The Fly
Dermata Therapeutics reports Q1 EPS (47c) vs. ($2.27) last year
9M ago
Dermata Therapeutics Inc trading halted, news pending
Premium
The Fly
Dermata Therapeutics Inc trading halted, news pending
9M ago
Dermata Therapeutics issues new patent in Japan for DMT410 program
PremiumThe FlyDermata Therapeutics issues new patent in Japan for DMT410 program
1y ago
Dermata Therapeutics files to sell 7.19M shares of common stock for holders
Premium
The Fly
Dermata Therapeutics files to sell 7.19M shares of common stock for holders
1y ago
Dermata Therapeutics to begin enrollment in DMT310 Phase 3 program in December
Premium
The Fly
Dermata Therapeutics to begin enrollment in DMT310 Phase 3 program in December
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100